Every year, millions of newborns undergo routine screening as a preventive strategy to detect inherited disorders before symptoms emerge. Newborn screening (NBS) programs have traditionally relied on ...

A review explores how next-generation sequencing may expand newborn screening and highlights key clinical and ethical ...

According to Nova One Advisor, the global next-generation sequencing market size is calculated at USD 17.37 billion in 2026 ...

Life sciences and diagnostics company Revvity has had a busy couple of years, playing a major role in the next-generation sequencing-based screening of newborns to better enable healthcare ...

BOSTON and SAN DIEGO, Nov. 11, 2025 /PRNewswire/ -- SOPHiA GENETICS (SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology company transforming the pace and ...

The non-coding genome, once dismissed as "junk DNA", is now recognized as a fundamental regulator of gene expression and a key player in understanding complex diseases. Following the landmark ...

Miami University’s Center for Bioinformatics and Functional Genomics (CBFG) has become one of the first institutions in the region to acquire the PacBio VEGA Benchtop System — a cutting-edge DNA ...

Opportunities in the Next Generation Cancer Diagnostics Market include leveraging advancements in genomic and proteomic ...

The growing use of precision medicine and genomics drives the sector. The global next-generation sequencing services market is expected to reach $8.77b by 2030 at a compound annual growth rate (CAGR) ...

According to MarketsandMarkets™, the Next-Generation Sequencing Market is projected to grow from about USD 14.94 billion in ...